US Patent 7807153 Apo-2 receptor agonist antibodies
Patent 7807153 was granted and assigned to Genentech on October, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+219 characters)
Article
Patent abstract
Novel polypeptides, designated Apo-2, which are capable of modulating apoptosis are provided. Compositions including Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 are also provided.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Anan Chuntharapai0
Avi J. Ashkenazi0
Camellia W. Adams0
Kyung Jin Kim0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07807153 Apo-2 receptor agonist antibodies US Patent 7807153 Apo-2 receptor agonist antibodies
Infobox
Patent Number
078071530
Patent Number
78071530
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078071530
Date of Patent
October 5, 2010
0Patent Application Number
104234480
Date Filed
April 25, 2003
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07807153 Apo-2 receptor agonist antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07807153
Date of patent
October 5, 2010
Patent application number
10423448
Date Filed
April 25, 2003
Patent primary examiner
Find more entities like US Patent 7807153 Apo-2 receptor agonist antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
